Page last updated: 2024-08-23

idarubicin and B16 Melanoma

idarubicin has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koning, GA; Lokerse, WJM; Lu, T; Seynhaeve, ALB; Ten Hagen, TLM1

Other Studies

1 other study(ies) available for idarubicin and B16 Melanoma

ArticleYear
Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Dec-28, Volume: 220, Issue:Pt A

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Compounding; Drug Stability; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Idarubicin; Kinetics; Lipids; Liposomes; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Nude; Polyethylene Glycols; Skin Neoplasms; Solubility; Temperature; Tumor Burden; Xenograft Model Antitumor Assays

2015